Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213)
Clinical trial NCT04434937 · COMPLETED
Trial details
- NCT number
- NCT04434937
- Sponsor
- Incyte Biosciences Japan GK
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-02-16
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.